Cas:3698-83-7 1,3-Dichloro-4,6-dinitrobenzene manufacturer & supplier

We serve Chemical Name:1,3-Dichloro-4,6-dinitrobenzene CAS:3698-83-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1,3-Dichloro-4,6-dinitrobenzene

Chemical Name:1,3-Dichloro-4,6-dinitrobenzene
CAS.NO:3698-83-7
Synonyms:1,3-Dichloro-4,6-dinitrobenzene;Benzene, 1,5-dichloro-2,4-dinitro-;MFCD00024186;1,3,-Dichloro-4,6-dinitrobenzene;1,5-Dichloro-2,4-dinitrobenzene;EINECS 223-027-1
Molecular Formula:C6H2Cl2N2O4
Molecular Weight:236.997
HS Code:2904909090

Physical and Chemical Properties:
Melting point:101-104 °C(lit.)
Boiling point:337.6±37.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.636
PSA:91.64000
Exact Mass:235.939163
LogP:2.52

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9/PG 3
Packing Group:III


Contact us for information like 1,3-Dichloro-4,6-dinitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 223-027-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00024186 Use and application,1,3,-Dichloro-4,6-dinitrobenzene technical grade,usp/ep/jp grade.


Related News: ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 1,3-Dichloro-4,6-dinitrobenzene manufacturer An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 1,3-Dichloro-4,6-dinitrobenzene supplier During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. 1,3-Dichloro-4,6-dinitrobenzene vendor The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. 1,3-Dichloro-4,6-dinitrobenzene factory An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.